DPEEX

DPEEX
AI-powered multi-omics platform for early breast cancer detection and risk prediction.
About
What does DPEEX do?
DPEEX develops a multi-omics, AI risk prediction toolkit designed to detect and localize breast cancer more than 24 months before it is visible to the naked eye. The company aims to sit at the center of a new CDx precision medicine ecosystem, linking radiology, life sciences, and biopharma.
What is DPEEX's revenue?
StartupHub estimates DPEEX's annual revenue at $717K (range $393K to $1.0M, 66% confidence), based on comparable companies in the sector.
When was DPEEX founded?
DPEEX was founded in 2017.
What industry does DPEEX operate in?
DPEEX operates in Healthcare, Cancer, Life Sciences, HealthTech, MedTech, Genomics.
How many employees does DPEEX have?
DPEEX has approximately 4 people on record.
What is DPEEX's current status?
DPEEX's current operating status is: Inactive.
No comments yet. Be the first to share your take.